The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with high-risk non-muscle invasive bladder cancer (NMIBC) who undergo radical cystectomy after BCG and subsequent salvage intravesical therapy.
 
Vignesh T. Packiam
Honoraria - CG Oncology
 
Craig V. Labbate
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - Ferring; Sanofi
 
Robert F. Tarrell
No Relationships to Disclose
 
Brittany Adamic
No Relationships to Disclose
 
Mohammad Mahmoud
No Relationships to Disclose
 
Matvey Tsivian
No Relationships to Disclose
 
Svetlana Avulova
No Relationships to Disclose
 
John Cheville
No Relationships to Disclose
 
R. Jeffrey Karnes
No Relationships to Disclose
 
Matthew K. Tollefson
No Relationships to Disclose
 
Ryan P. Werntz
No Relationships to Disclose
 
Gary D. Steinberg
Honoraria - AstraZeneca; Baxter; BioCancell; Bristol-Myers Squibb; CG Oncology; Epivax Oncology; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Heat Biologics; Janssen Oncology; MDxHealth; Merck; Natera; Photocure; Roche/Genentech; Sesen Bio; Taris Biomedical; Telesta Therapeutics; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical
 
Igor Frank
No Relationships to Disclose